Biology Webinar | Autism Spectrum Disorder: From Bench to Molecular Mechanisms
the chair
10th Biology Webinar
Autism Spectrum Disorder: From Bench to Molecular Mechanisms
Autism Spectrum Disorder is a complex neurobiological condition that affects approximately 1 in 31 children as of 2026. While traditionally defined by behavioral markers—such as challenges in social communication and restricted, repetitive patterns of behavior—modern research has shifted toward a "biologically anchored" framework that seeks to link these outward traits to their internal molecular origins. Autism Spectrum Disorder: From Bench to Molecular Mechanisms serves as a comprehensive guide to this evolving landscape, bridging the gap between basic laboratory research and the clinical reality of the disorder.
This webinar explores these "points of biological convergence," including:
- Systemic Interactions: new evidence linking Autism Spectrum Disorder to neuroimmune dysregulation, providing a "brain-body" perspective on the disorder.
- Translational Advances: the use of stem cells technology to model human development and test personalized therapeutic targets, as well as to provide newest treatment tools and approaches.
This webinar provides young investigators, clinicians and students with the necessary tools to understand Autism Spectrum Disorder not just as a set of symptoms, but as a diverse spectrum of precisely defined molecular mechanisms.
Meet Our Chair
Department of Experimental Medicine, University of Campania, 80138 Naples, Italy;Dr. Dario Siniscalco is biochemist/molecular biologist for the Department of Experimental Medicine, Division of Biotechnology and Molecular Biology of the University of Campania “Vanvitelli”, Italy. He graduated in Chemistry from the University of Naples “Federico II” in 2000 and received his Ph.D. in Pharmacological Sciences from the Second University of Naples in 2004. He completed his neuropathology fellowship at University of Alabama at Birmingham, USA, before joining the Second University of Naples staff in 2006. Dr. Siniscalco is registered member of the scientific societies: Order of the Chemists of Campania, National Council for Chemistry, International Association of Neurorestoratology. He is a co-founder of Stem Cell Research Italy. Author or co-author of 116 scientific peer-reviewed articles and 13 book chapters. His works received more than 3,500 citations so far. Presented more than 100 communications/abstracts to national and international conferences. He is serving as an editorial board member and reviewer of more than 60 international journals. He has also extensive expertises in scientifing writing, editing, proofreading. In 2010, he founded a research group to study cellular and molecular changes in autism spectrum disorders (ASD). His main research interests: gene expression and molecular regulation in ASD; use of stem cells as therapeutic tool in ASD; role of monocyte/macrophage activation in ASD. In 2012, together with prof. Alessio Fasano, he published a first pioneristic work on a macromolecular enzymatic system involvement in ASD. Now, dr. Siniscalco, for the EBRIS foundation, is the Italian principal investigator of the EU Horizon-granted GEMMA (Genome, Environment, Microbiome, Metabolome in Autism) project. Other research interests: stem cells therapy for the neuronal recovery; studying of neuronal apoptosis. Role of bcl-2 family, caspases, and cell cycle regulator genes. Full publication list is here: Orcid Scopus h-index: 34 WoS h-index: 34
Meet Our Speakers
Department of Immunology. Instituto de Ciencias Básicas y Preclínicas “Victoria de Girón”. Universidad de Ciencias Médicas de La Habana, La Habana, Cuba.;Bernal-Reyes graduated in nursing and he is currently studying medicine. He has interest in the field of neuroscience, focusing on the neuroplasticity in neurodevelopmental disorders. https://sciprofiles.com/profile/5499433
Department of Experimental Medicine, University of Campania “Vanvitelli”, Naples, Italy.;Deanira Patrone, PhD, is a Postdoctoral Researcher at the University of Campania "Luigi Vanvitelli" specializing in molecular biology and stem cell research. Her expertise spans stem cell isolation, characterization, and neural differentiation, with a core focus on utilizing human mesenchymal and MUSE stem cells to explore therapeutic avenues for autism spectrum and neuropsychotic disorders. Alongside an international research stay at the Carlos III Health Institute in Madrid, Dr. Patrone has presented her findings at prestigious European conferences, including the ECNP and StemNet meetings. She is extensively published in top-tier journals such as Molecular Psychiatry, Biology and the International Journal of Molecular Sciences.
Autism Spectrum Disorder: From Bench to Molecular Mechanisms
Edited by Dr. Dario Siniscalco
Deadline for manuscript submissions: 31 January 2027
This is a FREE webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Certificates of attendance will be delivered to those who attend the live webinar.
Can't attend? Register anyway and we'll let you know when the recording is available to watch.
-6ac76396657c5.png){kind=logo}
